85 related articles for article (PubMed ID: 3118105)
21. Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.
Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B
Cancer Res; 1993 Jan; 53(2):401-9. PubMed ID: 7678076
[TBL] [Abstract][Full Text] [Related]
22. Colocalization of elastase and myeloperoxidase in human blood and bone marrow neutrophils using a monoclonal antibody and immunogold.
Cramer EM; Beesley JE; Pulford KA; Breton-Gorius J; Mason DY
Am J Pathol; 1989 Jun; 134(6):1275-84. PubMed ID: 2547320
[TBL] [Abstract][Full Text] [Related]
23. Megakaryoblastic leukemia: the characterization and identification of megakaryoblasts.
Koike T
Blood; 1984 Sep; 64(3):683-92. PubMed ID: 6087961
[TBL] [Abstract][Full Text] [Related]
24. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies specific for human platelet membrane glycoproteins bind to monocytes by focal absorption of platelet membrane fragments: an ultrastructural immunogold study.
Breton-Gorius J; Lewis JC; Guichard J; Kieffer N; Vainchenker W
Leukemia; 1987 Feb; 1(2):131-41. PubMed ID: 3669739
[TBL] [Abstract][Full Text] [Related]
26. Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia. II. Studies with monoclonal antibodies and terminal transferase.
San Miguel JF; Tavares de Castro J; Matutes E; Rodriguez B; Polli N; Zola H; McMichael AJ; Bollum FJ; Thompson DS; Goldman JM
Br J Haematol; 1985 Feb; 59(2):297-309. PubMed ID: 3882137
[TBL] [Abstract][Full Text] [Related]
27. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
[TBL] [Abstract][Full Text] [Related]
28. Differential distribution of salivary agglutinin and amylase in the Golgi apparatus and secretory granules of human salivary gland acinar cells.
Takano K; Bogert M; Malamud D; Lally E; Hand AR
Anat Rec; 1991 Jul; 230(3):307-18. PubMed ID: 1714258
[TBL] [Abstract][Full Text] [Related]
29. Ferritin H is a novel marker of early erythroid precursors and macrophages.
Wang W; Grier DD; Woo J; Ward M; Sui G; Torti SV; Torti FM; Beaty MW
Histopathology; 2013 May; 62(6):931-40. PubMed ID: 23611361
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies against human hemopoietic cells and the separation of progenitor cells from bone marrow.
Mouchiroud G; Berthier R; Newton IA; Chapel A; Hollard D
Exp Hematol; 1985 Jul; 13(6):566-73. PubMed ID: 3996493
[TBL] [Abstract][Full Text] [Related]
31. Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotypes in some but not all cases.
Coulombel L; Eaves C; Kalousek D; Gupta C; Eaves A
J Clin Invest; 1985 Mar; 75(3):961-9. PubMed ID: 3856572
[TBL] [Abstract][Full Text] [Related]
32. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
34. [Possibilities of the immunodiagnosis of erythroleukemia].
Tupitsyn NN; Frenkel' MA; Volkova MA; Baryshnikov AIu
Ter Arkh; 1989; 61(4):127-9. PubMed ID: 2763179
[TBL] [Abstract][Full Text] [Related]
35. Immunological characterization of the leukemic megakaryocytic line at light and electron microscopic levels.
Tabilio A; Vainchenker W; Van Haecke D; Vinci G; Guichard J; Henri A; Reyes F; Breton-Gorius J
Leuk Res; 1984; 8(5):769-81. PubMed ID: 6492854
[TBL] [Abstract][Full Text] [Related]
36. Megakaryocytic leukemia and platelet factor 4.
Ryo R; Yasunaga M; Saigo K; Yamaguchi N
Leuk Lymphoma; 1992 Nov; 8(4-5):327-36. PubMed ID: 1337850
[TBL] [Abstract][Full Text] [Related]
37. Acute erythroblastic leukemia. Cytological, cytogenetic and phenotypic studies in one case.
Soler J; Pujol-Moix N; Bosch MA; Guanyabens C; Aventin A; Boque C; Brunet S
Acta Haematol; 1989; 82(2):102-5. PubMed ID: 2508392
[TBL] [Abstract][Full Text] [Related]
38. Survival of highly proliferative colony forming cells after treatment of bone marrow cells with 4-hydroperoxycyclophosphamide.
Komatsu N; Suda T; Suda J; Miura Y
Cancer Res; 1987 Dec; 47(23):6371-6. PubMed ID: 3677081
[TBL] [Abstract][Full Text] [Related]
39. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis.
Furukawa T; Koike T; Ying W; Kishi K; Aoki S; Gotoh T; Hashimoto S; Saitoh H; Hanano M; Shinada S
Leukemia; 1994 Jan; 8(1):171-80. PubMed ID: 8289484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
